The Mount Sinai Health System Names New Vice Chair of Neurosurgery and Director of the Cerebrovascular Surgery Program
Internationally regarded as a leader in the treatment of blood vessel diseases of the brain, neck and spine, J Mocco, MD, has been appointed Vice Chair for Education in the Department of Neurosurgery and Director of the Cerebrovascular Surgery Program for the Mount Sinai Health System.
“Dr. Mocco brings recognized expertise in clinical trial design and implementation as well as clinical acumen to his new role at Mount Sinai,” says Joshua Bederson, MD, Chairman of Neurosurgery for the Mount Sinai Health System. “We look forward to our cerebrovascular surgery program thriving under his leadership.”
As Director of the Cerebrovascular Surgery Program, Dr. Mocco will oversee a team of world-renowned experts in cerebrovascular disease to ensure that Mount Sinai continues to provide the very best cerebrovascular care available in New York, while continuing as a global leader in the treatment of cerebrovascular disease.
In his new role as the Vice Chair for Education, Dr. Mocco will supervise physician education across the system-wide Department of Neurosurgery, using state-of-the-art methodologies to most effectively teach the next generation of neurosurgeons. A robust physician education curriculum will ensure that current and future patients receive the best possible treatment for their neurologic conditions.
“It is my pleasure to be joining such an esteemed group of neurosurgical colleagues, many of whom have already made such impressive strides in the treatment of cerebrovascular disease,” says Dr. Mocco. “I am eager to collaborate with the team and to bring my passion for research, education and innovation to the table so we can maximize our ability to impact the medical community and the many patients who turn to us for help.”
Dr. Mocco’s clinical interests are in the treatment of stroke, brain aneurysms, intracerebral hemorrhage, arteriovenous malformations, cavernous malformations, carotid artery stenosis, intracranial stenosis and other blood vessel diseases of the brain, neck and spine. The principal investigator for several global clinical trials, his research interests focus on translational efforts to treat ischemic and hemorrhagic stroke.
Dr. Mocco received his medical degree from Columbia University College of Physicians and Surgeons. He completed his Master of Science in Biostatistics from the Mailman School of Public Health at Columbia University, an internship in General Surgery at New York Presbyterian Hospital and a research fellowship in Neurological Surgery at Columbia University. He also completed a residency in Neurosurgical Surgery from the Neurological Institute of New York and a fellowship in Endovascular Neurosurgery from the University at Buffalo.
Prior to joining Mount Sinai, Dr. Mocco was an Associate Professor of Neurological Surgery, Radiology and Radiological Sciences at Vanderbilt University Medical Center.
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.